Ono Pharma has offered $25.60 per share in cash, a premium of 74.7 per cent to U.S.-based Deciphera’s last closing price of $14.65 while some shareholders who own about 28% of Deciphera’s outstanding stock have already agreed to tender their shares and support the deal, which is expected to close in the third quarter of 2024,
News
Japan’s Ono to buy US drugmaker Deciphera for $2.4 bln
May 14, 2024
Ono Pharma has offered $25.60 per share in cash, a premium of 74.7 per cent to U.S.-based Deciphera’s last closing price of $14.65 while some shareholders who own about 28% of Deciphera’s outstanding stock have already agreed to tender their shares and support the deal, which is expected to close in the third quarter of 2024,